0 reactions
indianmarketgrid FYB206 is the first publicly announced proposed Keytruda biosimilar accepted for US review, with a decision potentially due in the third quarter of 2027.
READ FULL ANALYSIS MEMBER ANALYSIS
THE IMG COMMUNITY
Market insights. Fresh perspectives. Your conversation.
indianmarketgrid FYB206 is the first publicly announced proposed Keytruda biosimilar accepted for US review, with a decision potentially due in the third quarter of 2027.